Evidence from a few studies indicates the existence of several issues related to psychiatric patients’ decisional capacity to give informed consent to clinical research. Clinicians often face difficulties in acquiring valid informed consent in clinical practice and even more so in drug trials. Participants often fail to fully understand or retain information regarding the actual implications of research protocols. The Brief Assessment for Consent to Clinical Research (BACO) was developed to investigate capacity to consent to clinical trials and further compare patients with schizophrenia and healthy comparisons’ decisional capacity. A method to avoid possible confounding effects of choosing a treatment regarding a current disease was applied. The study groups were administered the BACO and the MacArthur Competence Assessment Tool for Clinical Research. Psychiatric patients performed poorer in comprehending, appreciating, and reasoning abilities, than their healthy counterparts. Impaired cognitive functioning and psychiatric symptoms severity were associated with reduced capacity to consent.

Decisional capacity to consent to clinical research involving placebo in psychiatric patients / Parmigiani, Giovanna; Mandarelli, Gabriele; Dacquino, Claudia; Pompili, PIERITALO MARIA; LELLI-CHIESA, Giovanni; Ferracuti, Stefano. - In: JOURNAL OF FORENSIC SCIENCES. - ISSN 0022-1198. - 61:2(2016), pp. 388-393. [10.1111/1556-4029.13000]

Decisional capacity to consent to clinical research involving placebo in psychiatric patients

PARMIGIANI, GIOVANNA;
2016

Abstract

Evidence from a few studies indicates the existence of several issues related to psychiatric patients’ decisional capacity to give informed consent to clinical research. Clinicians often face difficulties in acquiring valid informed consent in clinical practice and even more so in drug trials. Participants often fail to fully understand or retain information regarding the actual implications of research protocols. The Brief Assessment for Consent to Clinical Research (BACO) was developed to investigate capacity to consent to clinical trials and further compare patients with schizophrenia and healthy comparisons’ decisional capacity. A method to avoid possible confounding effects of choosing a treatment regarding a current disease was applied. The study groups were administered the BACO and the MacArthur Competence Assessment Tool for Clinical Research. Psychiatric patients performed poorer in comprehending, appreciating, and reasoning abilities, than their healthy counterparts. Impaired cognitive functioning and psychiatric symptoms severity were associated with reduced capacity to consent.
2016
61
2
388
393
Decisional capacity to consent to clinical research involving placebo in psychiatric patients / Parmigiani, Giovanna; Mandarelli, Gabriele; Dacquino, Claudia; Pompili, PIERITALO MARIA; LELLI-CHIESA, Giovanni; Ferracuti, Stefano. - In: JOURNAL OF FORENSIC SCIENCES. - ISSN 0022-1198. - 61:2(2016), pp. 388-393. [10.1111/1556-4029.13000]
Parmigiani, Giovanna; Mandarelli, Gabriele; Dacquino, Claudia; Pompili, PIERITALO MARIA; LELLI-CHIESA, Giovanni; Ferracuti, Stefano
File in questo prodotto:
File Dimensione Formato  
Parmigiani_Decisional capacity to consent_2016.pdf

Accesso riservato

Dimensione 93.91 kB
Formato Adobe PDF
93.91 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1371868
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 11
social impact